Diabetes prevalence decreased for both men and women from 2013 to 2017 and for all age groups studied starting in 2013 or 2014 through 2017. Although results varied by geographic region, diabetes prevalence either decreased or leveled off in all regions. Diabetes prevalence for American Indian and Alaska Native adults remained higher in 2017 than that seen in other studies of the general US adult population and other racial/ethnic groups.
Although it is not possible to determine specific reasons for these decreases, there are many potential contributors, including improvements in type 2 diabetes prevention services by IHS, tribal, and urban Indian health facilities. Key to these efforts is the Special Diabetes Program for Indians, commonly referred to as SDPI, which provides funding for type 2 diabetes prevention and diabetes treatment services to 301 programs in Native communities throughout the United States. Diabetes prevalence in a population is primarily affected by diabetes diagnoses in a given time period and diabetes-related mortality. The decrease in prevalence seen in this study is especially noteworthy because it occurred at the same time that diabetes-related mortality in Native patients was also decreasing, suggesting the decrease was driven by fewer new cases of diabetes. While we are encouraged by these positive outcomes, we know that there is still work to be done. The IHS will continue to include type 2 diabetes prevention and diabetes treatment among our highest priorities.
Rear Adm. Michael D. Weahkee, an enrolled member of the Zuni Tribe, is director of the Indian Health Service. He administers a nationwide health care delivery program that is responsible for providing preventive, curative, and community health care for approximately 2.6 million American Indians and Alaska Natives.
Join the Conversation